Gemma Montalban is a postdoctoral researcher at the CHU de Québec – Université Laval, where she is developing her project at Dr. Jacques Simard and Dr. Jean-Yves Masson laboratories. Her main research interest focuses on the molecular study and clinical interpretation of genetic variants in breast/ovarian cancer predisposing genes. She obtained her doctoral degree in Biomedicine at the University of Barcelona, where she studied the consequences of genetic variants on splicing and their clinical implications. She is currently working on developing large-scale functional assays to understand the molecular impact of genetic variants in DNA repair genes by coupling in vitro assays with next-generation sequencing technologies. She has interest in translational research and in accelerating the interpretation of genomic data to personalise diagnosis and treatment of cancer patients.